Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin F Sprinzl

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
United European Gastroenterology Journal|March 12, 2021
High pretreatment static and dynamic alpha-fetoprotein values predict reduced overall survival in hepatocellular carcinomaCarolin Czauderna, Irene Schmidtmann, Sandra Koch, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 17, 2007
Efficacy of an escalating dose regimen of pegylated interferon alpha-2a plus ribavirin in the early phase of HCV reinfection after liver transplantationTim Zimmermann, Wulf O Böcher, Stefan Biesterfeld, et al.
Journal of Clinical Medicine|February 12, 2021
No Evidence for Classic Thrombotic Microangiopathy in COVID-19Tanja Falter, Heidi Rossmann, Philipp Menge, et al.
Cellular and Molecular Gastroenterology and Hepatology|September 9, 2017
Hepatitis B Virus Activates Signal Transducer and Activator of Transcription 3 Supporting Hepatocyte Survival and Virus ReplicationMarianna Hösel, Maria Quasdorff, Marc Ringelhan, et al.
Liver Cancer|November 27, 2019
Improved Prediction of Survival by a Risk Factor-Integrating Inflammatory Score in Sorafenib-Treated Hepatocellular CarcinomaMartin F Sprinzl, Martha M Kirstein, Sandra Koch, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 19, 2012
No beneficial effect of all-trans retinoic acid in previous non-responder patients with chronic hepatitis C: the ATRACTION study, a phase II randomised trialMarcus Schuchmann, Jens M Kittner, Jörg F Schlaak, et al.
Journal of Thrombosis and Haemostasis : JTH|July 9, 2021
Pathogenic lipid-binding antiphospholipid antibodies are associated with severity of COVID-19Anne Hollerbach, Nadine Müller-Calleja, Denise Pedrosa, et al.
Oncotarget|April 19, 2017
Adverse genomic alterations and stemness features are induced by field cancerization in the microenvironment of hepatocellular carcinomasDarko Castven, Michael Fischer, Diana Becker, et al.
European Journal of Internal Medicine|June 4, 2018
Recipient liver function before liver transplantation influences post-transplantation survival in patients with HCCFriedrich Foerster, Jens Mittler, Felix Darstein, et al.
Gastroenterology|June 9, 2015
T Cells Engineered to Express a T-Cell Receptor Specific for Glypican-3 to Recognize and Kill Hepatoma Cells In Vitro and in MiceChristina Dargel, Michal Bassani-Sternberg, Julia Hasreiter, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
United European Gastroenterology Journal|March 12, 2021
High pretreatment static and dynamic alpha-fetoprotein values predict reduced overall survival in hepatocellular carcinomaCarolin Czauderna, Irene Schmidtmann, Sandra Koch, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 17, 2007
Efficacy of an escalating dose regimen of pegylated interferon alpha-2a plus ribavirin in the early phase of HCV reinfection after liver transplantationTim Zimmermann, Wulf O Böcher, Stefan Biesterfeld, et al.
Journal of Clinical Medicine|February 12, 2021
No Evidence for Classic Thrombotic Microangiopathy in COVID-19Tanja Falter, Heidi Rossmann, Philipp Menge, et al.
Cellular and Molecular Gastroenterology and Hepatology|September 9, 2017
Hepatitis B Virus Activates Signal Transducer and Activator of Transcription 3 Supporting Hepatocyte Survival and Virus ReplicationMarianna Hösel, Maria Quasdorff, Marc Ringelhan, et al.
Liver Cancer|November 27, 2019
Improved Prediction of Survival by a Risk Factor-Integrating Inflammatory Score in Sorafenib-Treated Hepatocellular CarcinomaMartin F Sprinzl, Martha M Kirstein, Sandra Koch, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 19, 2012
No beneficial effect of all-trans retinoic acid in previous non-responder patients with chronic hepatitis C: the ATRACTION study, a phase II randomised trialMarcus Schuchmann, Jens M Kittner, Jörg F Schlaak, et al.
Journal of Thrombosis and Haemostasis : JTH|July 9, 2021
Pathogenic lipid-binding antiphospholipid antibodies are associated with severity of COVID-19Anne Hollerbach, Nadine Müller-Calleja, Denise Pedrosa, et al.
Oncotarget|April 19, 2017
Adverse genomic alterations and stemness features are induced by field cancerization in the microenvironment of hepatocellular carcinomasDarko Castven, Michael Fischer, Diana Becker, et al.
European Journal of Internal Medicine|June 4, 2018
Recipient liver function before liver transplantation influences post-transplantation survival in patients with HCCFriedrich Foerster, Jens Mittler, Felix Darstein, et al.
Gastroenterology|June 9, 2015
T Cells Engineered to Express a T-Cell Receptor Specific for Glypican-3 to Recognize and Kill Hepatoma Cells In Vitro and in MiceChristina Dargel, Michal Bassani-Sternberg, Julia Hasreiter, et al.
Pageof 5